Sustainability
Examining how personalised medicine approaches will impact economic and environmental sustainability of healthcare provision and how these impacts can be mitigated.
Financial and economic sustainability
The personalisation of healthcare approaches often involves complex tests and interventions with uncertain outcomes. Considering resource constraints and costs ensures that personalised medicine remains accessible and affordable for patients. By understanding economic implications, healthcare systems can make evidence-based decisions about resource allocation and prioritise interventions based on evidence of value for money. It is crucial to have robust
methodologies and evidence for assessing these impacts to ensure that personalised medicine approaches are available to everyone.
The CPM is exploring considerations of financial and economic sustainability in personalised medicine through the lens of the CPM’s three pillar themes: 1) diagnosis and treatment, 2) risk and prevention, and 3) evolving health system boundaries.
Environmental sustainability
The environmental impact of personalised medicine projects may widen health inequalities for less affluent countries. Recognising, tackling, and learning from the uncertainties that personalised medicine presents is a priority for the CPM. This includes facilitating honest conversations so that these issues can be navigated, helping to identify and agree appropriate tradeoffs; and engaging with diverse stakeholders and policy makers.
The CPM is exploring considerations of environmental sustainability in personalised medicine through the lens of the CPM’s three pillar themes: 1) diagnosis and treatment, 2) risk and prevention, and 3) evolving health system boundaries.
